First published 10/3/2026, 1:19:15 AM · Last updated 10/3/2026, 1:19:15 AM

PL03.16 Spread Through Airspaces (STAS) and Prognosis in the Phase III JCOG0802/WJOG4607L Trial of Segmentectomy vs Lobectomy in NSCLC

A journal article reports an analysis of spread-through-airspaces (STAS) and its association with prognosis in a Phase III randomized trial comparing segmentectomy and lobectomy for non-small cell lung cancer (NSCLC). The supplied excerpt identifies the item as a journal article published by Elsevier BV but provides no trial results or outcome details.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 4/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 3/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The study examines prognosis-related factors in surgical treatment options for NSCLC.

Sources

PL03.16 Spread Through Airspaces (STAS) and Prognosis in the Phase III JCOG0802/WJOG4607L Trial of Segmentectomy vs Lobectomy in NSCLC

Report an issue